http://www.fpnotebook.com/
Active Tuberculosis TreatmentAka: Active Tb Treatment, Active Tuberculosis Special Circumstances, Drug-Induced Hepatitis from Antituberculous Drugs
- Protocols
- Susceptible Tb Treatment
- Possibly Resistant Tb Treatment
- Multiple Drug Resistant Tb Treatment
- Precautions
- Tuberculosis requires long-term treatment (6-24 months)
- Regimens for Tuberculosis treatment must be multi-drug
- Four drugs should be used initially until culture
- Never add a single drug to a failing regimen
- Patients must be monitored at least monthly
- Patient noncompliance is a major problem
- Consider intermittent therapy
- Consider Directly observed therapy
- Drug Interactions
- Review drug interactions before use (esp. Rifampin)
- Adverse Effects
- Gastrointestinal upset
- Consider taking medication with food
- Hepatotoxicity (AST 3-5x normal)
- See Also Hepatotoxin
- Consider alternatives below if advanced liver disease
- Drugs most likely to cause Drug-Induced Hepatitis
- Isoniazid
- Rifampin
- Pyrazinamide
- Alternative drugs if Drug-Induced Hepatitis occurs
- Capreomycin
- Fluoroquinolone
- Ethambutol
- Streptomycin
- Amikacin
- Kanamycin
- Management: Special Circumstances
- Human Immunodeficiency Virus Infection
- Avoid once weekly continuation phase protocols
- Pediatric patients
- Start empiric treatment immediately if suspected
- High risk of Disseminated tuberculosis
- Initial Protocol
- Three drug regimen indicated in most cases
- Regimen: Isoniazid, Pyrazinamide, Rifampin
- Ethambutol avoided due to decreased vision risk
- Four drug regimen (inc. Ethambutol) indications
- Upper lobe infitrate
- Cavitation
- Productive cough
- Pregnant Women
- Initial Regimen: Isoniazid, Rifampin, Ethambutol
- Give Pyridoxine 25 mg daily (prevents Neuropathy)
- Do not use Streptomycin in pregnancy
- Pyrazinamide appears safe in pregnancy
- Less studied, and avoided in some regimens
- Give 7 month continuation phase if no Pyrazinamide
- Lactation
- May continue to breast feed on antituberculous drugs
- Give Pyridoxine 25 mg daily (prevents Neuropathy)
- Management: Non-compliance
- General
- Compliance management is imperative
- Non-compliance causes treatment failures, resistance
- Dosing should be observed unless compliance assured
- Consider fixed dose combinations
- Rifater
- Contents
- Rifampin 120 mg
- Isoniazid 50 mg
- Pyrazinamide 300mg
- Treat for first 2 months of daily therapy
- Weight <44 kg: 4 tabs qd
- Weight 45-54 kg: 5 tabs qd
- Weight >55 kg: 6 tabs qd
- Rifamate
- Rifampin 300 mg
- Isoniazid 150 mg
- References
- Frieden (2003) Lancet 362:887
- Potter (2005) Am Fam Physician 72:2225
Navigation Tree